Stockreport

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF Up to $1.9 million up front with up to an additional $2.7 million of potential aggregate gross proceeds upon the exercise in full of common stock purchase warrantsHENDER [Read more]